skip to main content
Show Results with:

An ACT1 mutation selectively abolishes interleukin-17 responses in humans with chronic mucocutaneous candidiasis.

Immunity, October 17, 2013, Vol.39(4), pp.676-686 [Peer Reviewed Journal]

No full-text

Searching Remote Databases, Please Wait